أطروحة الماجستير للطالبة روان عمايري من قسم الصيدلة السريرية

ناقشت بنجاح طالبة الماجستير روان نبيل عمايري من قسم الصيدلة السريرية يوم الأربعاء الموافق 26/4/2017م أطروحة الماجستير بعنوان:

EVALUATING DRUG PRICES, AVAILABILITY AND AFFORDABILITY IN JORDAN

وقد ضمت لجنة المناقشة  الدكتور قيس العيفان رئيساً وعضوية كل من الدكتورة شروق الطوالبة والدكتورة سماح الشطناوي والدكتور غيث الطعاني كممتحن خارجي. باسم صفحة أصدقاء كلية الصيدلة_ في جامعة العلوم والتكنولوجيا الأردنية نبارك للطالبة روان عمايري إتمامها درجة الماجستير في الصيدلة السريرية بنجاح وتفوق متمنين لها مزيدا من التقدم.

للإطلاع على ملخص الدراسة

Background: Access to healthcare is a fundamental human right that is associated with free access to essential medicines. In fact, this access is affected by many factors such as high drugs prices, low availability, and low affordability of medicines. About one-third of the global population lacks reliable access to needed medicines, with this proportion being as high as 50% in some of the poorest countries of Africa and Asia. So, government should develop a framework to provide easily accessible and affordable health care for all populations.

Objective: To evaluate medicine prices, availability and affordability in public and private sectors in Jordan.

Method: The standardized methodology designed by the World Health Organization (WHO) and Health Action International (HAI) was used to survey 50 essential medicines. Data was collected from 30 public sectors and 30 private sectors in 6 regions in Jordan. At each facility, the availability and prices of 50 originator brand (OB) medicines and lowest-price generic (LPG) equivalent medicines were collected. Medicine prices were compared with international reference prices (IRPs) to obtain a median price ratio (MPR). Availability was determined on the day of data collection. Affordability was calculated in terms of the daily wage of the lowest-paid unskilled government worker.

Result: Mean availability in the public and private sector was 72% and 76% for LPGs, respectively. Median MPRs of procurement prices for OBs and LPGs in the public sector were 1.1 and 5.5 times the IRPs; respectively. Private sector OB medicines were priced 4.8 times higher than IRPs, whilst LPGs were 3.8 times higher. OBs cost 14% more than LPGs in private sector. The median MPRs of patient prices for LPGs in the public sector were lower than in the private sector (1.1 versus 7.6). For most of the population, the medicine prices are affordable in public sector that the lowest paid unskilled government worker need less than a one day income to purchase the LPGs. While in private sector, the medicine prices are not affordable. For example, the treatment of hypertension either by LPGs or OBs needs more than one day income by lowest paid unskilled government worker.

Conclusion: The study showed good availability of LPGs in the public sector. In private sector, it showed good availability of LPGs and OBs with higher patient prices. The procurement prices in the public sector were reasonable in comparison to IRPs. Policy evaluation efforts should be directed to reduce the medicine prices and to improve affordability in private sector.